Stocks
Bristol-Myers Squibb CompanyBMY
NYSEHealthcarePharmaceuticals$59.08+0.22%
A global biopharmaceutical manufacturer focused on developing and commercializing prescription medicines for cancer, cardiovascular disease, immunology, and other serious conditions. Its portfolio includes blockbuster therapies such as the cancer immunotherapy Opdivo and the anticoagulant Eliquis, w...
Market Cap: $120.3B52W Range: $42.52 – $62.89
Congressional Interest in Bristol-Myers Squibb Company (BMY)
17 members of Congress have disclosed 50 trades in Bristol-Myers Squibb Company (BMY), a Healthcare company. The buy/sell breakdown shows 22 purchases versus 28 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
17
Buys
22
Sells
28
Who in Congress Is Trading BMY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2023-10-24 | Greg Stanton | sell | $1K – $15K |
| 2023-10-17 | Thomas H Tuberville | buy | $1K – $15K |